Xilio Therapeutics Announces Pipeline and Business Updates

Will present initial Phase 1C dose escalation data for vilastobart (XTX101), a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab, in a late-breaker poster presentation at the SITC Annual Meeting Expect to report initial Phase 2 data in microsatellite stable colorectal cancer (MSS CRC) for vilastobart in combination with atezolizumab in the fourth quarter of 2024 … Read more

Windows AI updates will rewrite text in Notepad, edit images in Paint

Microsoft is adding more AI-powered features to its Notepad and Paint apps for Windows 11. Notepad version 11.2410.15.0 will include a new AI rewrite feature that will allow you to reword sentences using AI. The tool can edit sentences or longer sections of text to shorten or lengthen the number of words, change the tone, … Read more